About this trial
Pneumonia is one of the leading causes of infection-related mortality in the older population. Traditional severity scores used in emergency departments, such as the Pneumonia Severity Index (PSI) and CURB-65, primarily focus on acute physiological derangements and may not adequately capture biological reserve and frailty in older adults. Frailty is a geriatric syndrome reflecting increased vulnerability to stressors and reduced recovery capacity.
This prospective observational cohort study aims to evaluate the predictive value of the Clinical Frailty Scale (CFS) for in-hospital mortality, 30-day mortality, and morbidity in patients aged 65 years and older presenting to the emergency department with pneumonia. Additionally, the study will assess whether incorporating frailty assessment into existing pneumonia severity scores improves prognostic accuracy.
Eligibility criteria
Qualifiers
Age ≥65 years
Clinical and radiological diagnosis of pneumonia in the emergency department
Ability to obtain informed consent from the patient or legal representative
Availability of a caregiver or relative able to describe baseline functional status
Disqualifiers
Presentation with cardiopulmonary arrest or ongoing cardiopulmonary resuscitation at admission
Confirmed COVID-19 pneumonia
Inability to obtain reliable baseline functional history due to absence of an informant
Refusal to provide informed consent
Trial design
Treatments tested in this trial
- Clinical frailty scale
- Clinical Frailty Scale (CFS)